Yemuna Satya, M.D.
NPI 1790781771 · Cardiovascular Disease Physician · Sarasota, FL
Enrolled with Medicare as Practitioner - Cardiovascular Disease (cardiology) · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1790781771
- Entity type
- Individual
- Primary specialty
- Cardiovascular Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- Yes
- License
- ME81682 (FL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,923 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Routine Electrocardiogram (ecg) Using at Least 12 Leads With Interpretation and Report93000 | 556 | $14 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 375 | $124 |
| Ultrasound of Heart With Color-Depicted Blood Flow, Rate, Direction and Valve Function93306 | 199 | $183 |
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 165 | $176 |
| Technetium Tc-99m Tetrofosmin, Diagnostic, Per Study DoseA9502 | 148 | $441 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 39 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Metoprolol Succinate | 268 | 85 |
| Apixabanbrand: Eliquis | 231 | 63 |
| Amlodipine Besylate | 172 | 56 |
| Rosuvastatin Calcium | 148 | 47 |
| Diltiazem Hclbrand: Diltiazem 24hr Er (cd) | 143 | 46 |
| Rivaroxabanbrand: Xarelto | 129 | 31 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$797 across 37 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-06-23
- Last updated
- 2025-07-29
- Certified
- 2025-07-29
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.